Search for other papers by Véronique Raverot in
Google Scholar
PubMed
Search for other papers by Stéphanie Metrat in
Google Scholar
PubMed
Search for other papers by Pauline Perrin in
Google Scholar
PubMed
Search for other papers by Juliette Abeillon in
Google Scholar
PubMed
Search for other papers by Hélène Lasolle in
Google Scholar
PubMed
, inappropriate explorations and treatments. This observation adds to the literature as long-term evolution has been rarely studied ( 2 ). In the present case, biological abnormalities remained unchanged over time. Additionally, if case reports have described the
Search for other papers by Vittoria Guarda in
Google Scholar
PubMed
Search for other papers by Anja Pickhard in
Google Scholar
PubMed
Search for other papers by Melanie Boxberg in
Google Scholar
PubMed
Search for other papers by Katja Specht in
Google Scholar
PubMed
Search for other papers by Anna Maria Stefanie Buchberger in
Google Scholar
PubMed
What Is Known about This Topic? Liposarcomas of the thyroid gland are extremely rare, and there is no definitive consensus within the literature about a comprehensive treatment recommendation yet. What Does This Case Report Add
Search for other papers by Daniela Rodrigues Cavaco in
Google Scholar
PubMed
Search for other papers by Ana Alves Rafael in
Google Scholar
PubMed
Search for other papers by Rafael Cabrera in
Google Scholar
PubMed
Search for other papers by Helena Vilar in
Google Scholar
PubMed
NOVA Medical School/New University of Lisboa, Lisbon, Portugal
Search for other papers by Valeriano Leite in
Google Scholar
PubMed
symptoms. Novel Insights This is one of the few reported cases of diffuse lipomatosis with coexisting deposition of amyloid in the thyroid gland. Introduction Diffuse thyroid lipomatosis is a histopathological condition of
Search for other papers by Akshay Khatri in
Google Scholar
PubMed
Search for other papers by Esti Charlap in
Google Scholar
PubMed
Search for other papers by Angela Kim in
Google Scholar
PubMed
]. As of July 16, 2020, >13.3 million cases with >580,000 deaths have been reported globally [ 3 ]. The initial reported symptoms of COVID-19 in China were primarily respiratory symptoms associated with bilateral ground glass pulmonary opacities on
Search for other papers by Ringo Manta in
Google Scholar
PubMed
Search for other papers by Charlotte Martin in
Google Scholar
PubMed
Search for other papers by Vinciane Muls in
Google Scholar
PubMed
Search for other papers by Kris G Poppe in
Google Scholar
PubMed
Established facts SARS-CoV-2 can be complicated by different types of autoimmune thyroiditis. Few cases of Graves’ disease (GD) following SARS-CoV-2 (vaccination) have been reported. Novel insights A previous episode
Search for other papers by Darshan Patil in
Google Scholar
PubMed
Search for other papers by Abhay Kumaraswamy Kattepur in
Google Scholar
PubMed
Search for other papers by Srinivas Kodaganur Gopinath in
Google Scholar
PubMed
Search for other papers by Shivanand Swamy in
Google Scholar
PubMed
Search for other papers by Amarendra Shankarappa in
Google Scholar
PubMed
Search for other papers by Gopinath Kodaganur Srinivasachar in
Google Scholar
PubMed
, ray resection or curettage [ 5 ]. Choroidal metastases are among the commonest tumors involving the choroid.Ferry and Font [ 7 ] reported 1 case of uveal metastasis from thyroid cancer in their series of 227 cases. In a study of 420 patients with
Search for other papers by Shinsuke Shinkai in
Google Scholar
PubMed
Medical Education Center, Hamamatsu University School of Medicine, Shizuoka, Japan
Search for other papers by Kenji Ohba in
Google Scholar
PubMed
Search for other papers by Kennichi Kakudo in
Google Scholar
PubMed
Search for other papers by Takayuki Iwaki in
Google Scholar
PubMed
Search for other papers by Yoshihiro Mimura in
Google Scholar
PubMed
Search for other papers by Akio Matsushita in
Google Scholar
PubMed
Search for other papers by Go Kuroda in
Google Scholar
PubMed
Search for other papers by Yuki Sakai in
Google Scholar
PubMed
Search for other papers by Nobuhiko Nishino in
Google Scholar
PubMed
Department of Pharmacology, Hamamatsu University School of Medicine, Shizuoka, Japan
Search for other papers by Kazuo Umemura in
Google Scholar
PubMed
Search for other papers by Takafumi Suda in
Google Scholar
PubMed
Search for other papers by Shigekazu Sasaki in
Google Scholar
PubMed
What Is Known about This Topic? • Hyperfunctioning thyroid carcinoma is rare, and its molecular etiology is not clear. • To the best of our knowledge, there is no reported case of hyperfunctioning thyroid carcinoma with a BRAF mutation (a
Search for other papers by Alessandro Brancatella in
Google Scholar
PubMed
Search for other papers by Nicola Viola in
Google Scholar
PubMed
Search for other papers by Sandra Brogioni in
Google Scholar
PubMed
Search for other papers by Lucia Montanelli in
Google Scholar
PubMed
Search for other papers by Chiara Sardella in
Google Scholar
PubMed
Search for other papers by Paolo Vitti in
Google Scholar
PubMed
Search for other papers by Claudio Marcocci in
Google Scholar
PubMed
Search for other papers by Isabella Lupi in
Google Scholar
PubMed
Search for other papers by Francesco Latrofa in
Google Scholar
PubMed
contrary, Graves’ disease has been described in only eight patients during ICPis treatment, five during anti-CTLA-4 and three during anti-PD-1 treatment. We report the fourth case of Grave’s disease induced by anti-PD-1, the second with an overt
Search for other papers by Inês Damásio in
Google Scholar
PubMed
Search for other papers by Joana Simões-Pereira in
Google Scholar
PubMed
Nova Medical School, Lisbon, Portugal
Search for other papers by Sara Donato in
Google Scholar
PubMed
Search for other papers by Mariana Horta in
Google Scholar
PubMed
Search for other papers by Branca Maria Cavaco in
Google Scholar
PubMed
Search for other papers by Miguel Rito in
Google Scholar
PubMed
Search for other papers by Pedro Gomes in
Google Scholar
PubMed
Nova Medical School, Lisbon, Portugal
Search for other papers by Valeriano Leite in
Google Scholar
PubMed
. Novel insights We present the first reported case of a patient with an NTRK -positive ATC showing a successful response to neoadjuvant treatment with entrectinib. Introduction Anaplastic thyroid carcinoma (ATC) accounts for 1–2% of
Otorhinolaryngology, Tan Tock Seng Hospital, Singapore, Singapore
Search for other papers by Hao Li in
Google Scholar
PubMed
Otolaryngology, Head and Neck Surgery, Sheba Medical Center, Ramat Gan, Israel
Search for other papers by Nir Livneh in
Google Scholar
PubMed
Search for other papers by Snjezana Dogan in
Google Scholar
PubMed
Search for other papers by Ashok R. Shaha in
Google Scholar
PubMed
report of two cases . Endocr Pathol . 2004 ; 15 ( 1 ): 83 – 8 . http://dx.doi.org/10.1385/ep:15:1:83 . 7 Meshikhes AW , Tingura M , Al-Saeed JY . Concurrent papillary and medullary thyroid carcinomas with mixed metastases to lymph